Have a personal or library account? Click to login
Natural course of treated epilepsy and medico-social outcomes. Turku studies. Part II Cover

Natural course of treated epilepsy and medico-social outcomes. Turku studies. Part II

Open Access
|Jan 2016

References

  1. Abraham S., Shaju M.:Innovations in epilepsy management - an overview. J. Pharm. Pharm. Sci., 2013, 16: 564–576.10.18433/J32K5B
  2. Äikiä M., Kälviäinen R., Mervaala E., Riekkinen Sr PJ.:Predictors of seizure outcome in newly diagnosed partial epilepsy: memory performance as a prognostic factor. Epil. Res., 1999, 37: 159–167.10.1016/S0920-1211(99)00059-5
  3. Annegers J.F., Hauser W.A., Elveback L.R.:Remission of seizures and relapse in patients with epilepsy. Epilepsia, 1979, 20: 729–737.10.1111/j.1528-1157.1979.tb04857.x499118
  4. Artama M., Isojärvi J.I.T., Auvinen A.:Antiepileptic drug use and birth rate in patients with epilepsy - a population-based cohort study in Finland. Hum. Reprod., 2006, 21: 2290–2295.10.1093/humrep/del19416751648
  5. Artama M., Isojärvi J.I., Raitanen J., Auvinen A.:Birth rate among patients with epilepsy: a nationwide population-based cohort study in Finland. Am. J. Epidemiol., 2004, 159: 1057–1063.10.1093/aje/kwh14015155290
  6. Arts W.F., Brouwer O.F., Peters A.C., Stroink H., Peeters E.A., Schmitz P.I., Donselaar C.A., Geerts A.T.:Course and prognosis of childhood epilepsy: 5-year follow-up of the Dutch study of epilepsy in childhood. Brain, 2004, 127: 1774–1784.10.1093/brain/awh20015201192
  7. Astradsson A., Olafsson E., Ludvigsson P., Bjorgvinsson H., Hauser W.A.:Rolandic epilepsy: an incidence study in Iceland. Epilepsia, 1998, 39: 884–886.10.1111/j.1528-1157.1998.tb01185.x9701381
  8. Baker G.A., Spector S., McGrath Y., Soteriou H.:Impact of epilepsy in adolescence: a UK controlled study. Epilepsy Behav., 2005, 6: 556–562.10.1016/j.yebeh.2005.03.01115869907
  9. Balish M., Albert P., Theodore W.H.:Seizure frequency in intractable partial epilepsy: a statistical analysis. Epilepsia, 1991, 32: 642–649.10.1111/j.1528-1157.1991.tb04703.x1915170
  10. Beghi E., Cornaggia C.M.:Learning disorders in epilepsy. Epilepsia, 2006, Suppl. 2, 47: 14–18.10.1111/j.1528-1167.2006.00681.x17105453
  11. Berg A.T., Shinnar S., Levy S.R., Testa F.M.:Newly diagnosed epilepsy in children: presentation at diagnosis. Epilepsia, 1999, 40: 445–452.10.1111/j.1528-1157.1999.tb00739.x
  12. Berg A.T., Shinnar S., Levy S.R., Testa F.M., Smith-Rapaport S., Beckerman B.:Early development of intractable epilepsy in children: a prospective study. Neurology, 2001, 56: 1445–1452.10.1212/WNL.56.11.1445
  13. Berg A.T., Lin J., Ebrahimi N., Testa F.M., Levy S.R., Shinnar S.:Modeling remission and relapse in pediatric epilepsy: application of a Markov process. Epil. Res., 2004, 60: 31–40.10.1016/j.eplepsyres.2004.05.002
  14. Besag F.M.C.:Cognitive deterioration in children with epilepsy. In: M.R. Trimple, E.H. Reynolds (eds), Epilepsy, behaviour and Cognitive Function. John Wiley & Sons, Chichester, UK 1988, 113–127.
  15. Bouma P.A., Bovenkerk A.C., Westendorp R.G., Brouwer O.F.:The course of benign partial epilepsy of childhood with centrotemporal spikes: a meta-analysis. Neurology, 1997, 48: 430–437.10.1212/WNL.48.2.430
  16. Callaghan N., Crowley M., Goggin G.:Epilepsy and employment, marital, education, and social status. Ir. Med. J., 1992, 85: 17–19.
  17. Camfield C., Breau L., Camfield P.:Assessing the impact of pediatric epilepsy and concomitant behavioral, cognitive, and physical/neurologic disability: Impact of Childhood Neurologic Disability Scale. Developmental Medicine & Child Neurology, 2003, 45: 152–159.10.1111/j.1469-8749.2003.tb00923.x
  18. Camfield C.S., Camfield P.R.:Rolandic epilepsy has little effect on adult life 30 years later: a population-based study. Neurology, 2014, 82: 1162–1166.10.1212/WNL.0000000000000267
  19. Camfield C.S., Camfield P.R.:The adult seizures and social outcomes of children with partial complex seizures. Brain, 2013, 136: 593–600.10.1093/brain/aws352
  20. Camfield C.S., Camfield P.R.:Long-term social outcomes for children with epilepsy. Epilepsia, 2007, 48: 3–5.10.1111/j.1528-1167.2007.01390.x
  21. Camfield C., Camfield P., Gordon K., Smith B., Dooley J.:Outcome of childhood epilepsy: a population-based study with a simple predictive scoring system for those treated with medication. J. Pediatr., 1993, 122: 861–868.10.1016/S0022-3476(09)90008-7
  22. Camfield P.R., Camfield C.S., Gordon K., Dooley J.M.:If a first antiepileptic drug fails to control a child’s epilepsy, what are the chances of success with the next drug? J. Pediatr., 1997, 131: 821–824.10.1016/S0022-3476(97)70027-1
  23. Central Statistical Office of Finland:Classification of Socioeconomic Groups (In Finnish, with English summary). Central Statistical Office of Finland, Helsinki 1989.
  24. Fisher R.A., Acevado C., Arzimanoglou A., Bogacz A., Cross J.H., Elger C.E. et al.:ILAE Official Report: A practical clinical definition of epilepsy. Epilepsia, 2014, 55: 475–482.10.1111/epi.12550
  25. Forsgren L., Sillanpää M.:Natural course of epilepsies. In: H. Stefan, W Theodore (eds), Handbook of Neurology. Elsevier, Amsterdam 2012, 108, 643–661.10.1016/B978-0-444-52899-5.00020-4
  26. Gauffin H., Räty L., Söderfeldt B .:Medical outcome in epilepsy patients of young adulthood – a 5-year follow-up study. Seizure, 2009, 18: 293–297.10.1016/j.seizure.2008.11.009
  27. Goodridge D.M., Shorvon S.D.:Epileptic seizures in a population of 6000. II: Treatment and prognosis. Br. Med. J. (Clin. Res. Ed.), 1983, 287: 645–647.
  28. Haut S.R., Swick C., Freeman K., Spencer S.:Seizure clustering during epilepsy monitoring. Epilepsia, 2002, 43: 711–715.10.1046/j.1528-1157.2002.26401.x
  29. Haut S.R., Shinnar S., Moshe S.L., O’Dell C., Legatt A.D.:The association between seizure clustering and convulsive status epilepticus in patients with intractable complex partial seizures. Epilepsia, 1999, 40: 1832–1834.10.1111/j.1528-1157.1999.tb01607.x
  30. Heijbel J., Blom S., Bergfors P.G.:Benign epilepsy in children with centro-temporal EEG foci. A study of incidence rate in outpatient care. Epilepsia, 1975, 16: 657–664.10.1111/j.1528-1157.1975.tb04748.x
  31. International league Against Epilepsy. Commission on Classification and Terminology:Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia, 1989, 30: 389–399.10.1111/j.1528-1157.1989.tb05316.x
  32. International League against Epilepsy. Commission on Epidemiology and Prognosis, International League Against Epilepsy:Guidelines for epidemiologic studies on epilepsy. Epilepsia, 1993, 34: 592–596.10.1111/j.1528-1157.1993.tb00433.x
  33. International League Against Epielepsy. Commission on Revised Classification of Seizures:Proposal for revised clinical and electroencephalographic classification of epileptic seizures. From the Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia, 1981, 22: 489–501.10.1111/j.1528-1157.1981.tb06159.x
  34. Jacoby A., Baker G., Smith D., Dewey M., Chadwick D.:Measuring the impact of epilepsy: the development of a novel scale. Epilepsy Res., 1993, 16: 83–88.10.1016/0920-1211(93)90042-6
  35. Jalava M., Sillanpää M.:Reproductive activity and offspring health of young adults with childhood-onset epilepsy: a controlled study. Epilepsia, 1997, 38: 532–540.10.1111/j.1528-1157.1997.tb01137.x
  36. Jalava M, Sillanpää M.:Concurrent illnesses in adults with childhood-onset epilepsy: a population-based 35-year followup study. Epilepsia, 1996, 37: 1155–1163.10.1111/j.1528-1157.1996.tb00547.x
  37. Jenkinson C., Coulter A., Wright L.:Short form 36 (SF36) health survey questionnaire: normative data for adults of working age. BMJ, 1993, 306: 1437–1440.10.1136/bmj.306.6890.1437
  38. Ko T.S., Holmes G.L.:EEG and clinical predictors of medically intractable childhood epilepsy. Clin. Neurophysiol., 1999, 110: 1245–1251.10.1016/S1388-2457(99)00068-1
  39. Kokkonen J., Kokkonen E.R., Saukkonen A.L., Pennanen P.:Psychosocial outcome of young adults with epilepsy in childhood. J. Neurol. Neurosurg. Psychiatry, 1997, 62: 265–268.10.1136/jnnp.62.3.265
  40. Kwan P., Arzimanoglou A., Berg A.T., Brodie M.J., Hauser A.W., Mathern G. et al.:Definition of drug-resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE commission on therapeutic strategies. Epilepsia, 2010, 51: 1069–1077.10.1111/j.1528-1167.2009.02397.x
  41. Kwan P., Brodie M.J.:Early identification of refractory epilepsy. N. Engl. J. Med., 2000, 342: 314–319.10.1056/NEJM200002033420503
  42. Löscher W., Klitgaard H., Twyman R.E., Schmidt D.:New avenues for anti-epileptic drug discovery and development. Nat. Rev. Drug Discov., 2013, 12: 757–776.10.1038/nrd4126
  43. Luciano A.L., Shorvon S.D.:Results of treatment changes in patients with apparently drug-resistant chronic epilepsy. Ann. Neurol., 2007, 62: 375–381.10.1002/ana.21064
  44. MacDonald B.K., Johnson A.L., Goodridge D.M., Cockerell O.C., Sander J.W., Shorvon S.D.:Factors predicting prognosis of epilepsy after presentation with seizures. Ann. Neurol., 2000, 48: 833–841.10.1002/1531-8249(200012)48:6<;833::AID-ANA3>3.0.CO;2-U
  45. Manford M., Fish D.R., Shorvon S.D.:An analysis of clinical seizure patterns and their localizing value in frontal and temporal lobe epilepsy. Brain, 1996, 119: 17–40.10.1093/brain/119.1.178624679
  46. Ounsted C., Lindsay J., Richards P. (eds):Temporal lobe epilepsy 1948–1986: a biographical study. No. 103 of Clinics in developmental medicine. Mac Keith Press, London 1987.
  47. Perucca E.:Marketed new antiepileptic drugs: are they better than old-generation agents? Ther. Drug Monit., 2002, 24: 74–80.10.1097/00007691-200202000-0001311805726
  48. Randall W.S. (ed.):George Washington: a life. Henry Holt, New York 1997.
  49. Rodin E.A., Shapiro H.L., Lennox K.:Epilepsy and life performance. Rehab. Lit., 1977, 38: 34–39.
  50. Sander J.W.A.S., Sillanpää M.:Natural history and prognosis. In: J. Engels, T.A. Pedley (eds), Epilepsy. A Comprehensive Textbook. Volume I/III. Raven Press, New York 1997, 69–86.
  51. Sarkis R.A., Jehi L., Bingaman W., Najm I.M.:Seizure worsening and its predictors after epilepsy surgery. Epilepsia, 2012, 53: 1731–1738.10.1111/j.1528-1167.2012.03642.x22958128
  52. Schmidt D.:Efficacy of new antiepileptic drugs. Epilepsy Curr., 2011, 11: 9–11.10.5698/1535-7511-11.1.9306357421461260
  53. Schmidt D., Sillanpää M.:Does surgery prevent worsening of epilepsy? Epilepsia, 2013, 54: 391.10.1111/epi.1205223384344
  54. Schmidt D., Stavem K.:Long-term seizure outcome of surgery versus no surgery for drug-resistant partial epilepsy: a review of controlled studies. Epilepsia, 2009, 50: 1301–1309.10.1111/j.1528-1167.2008.01997.x19243421
  55. Schmidt D., Löscher W.:How effective is surgery to cure seizures in drug-resistant epilepsy? Epilepsy Res., 2003, 56: 85–91.10.1016/j.eplepsyres.2003.10.00414642992
  56. Seidenberg M.:Academic achievement and school performance of children with epilepsy. In: B.P. Hermann, M. Seidenberg (eds), Childhood Epilepsies. Neuropsychological, Psychosocial and Intervention Aspects. John Wiley, Chichester 1989, 105–118.
  57. Selwa L.M., Schmidt S.L., Malow B.A., Beydoun A.A.:Long-term outcome of nonsurgical candidates with medically refractory localization-related epilepsy. Epilepsia Res., 2003, 44: 1568–1572.10.1111/j.0013-9580.2003.15003.x14636329
  58. Shinnar S., Berg A.T., Moshe S.L., Kang H., O’Dell C., Alema-ny M. et al.:Discontinuing antiepileptic drugs in children with epilepsy: a prospective study. Ann. Neurol., 1994, 35: 534–545.10.1002/ana.4103505068179299
  59. Sillanpää M.:Long-term prognosis of adults with benign epilepsy of childhood. Epileptologia, 2010, 18: 117–123.
  60. Sillanpää M.:Learning disability: occurrence and long-term consequences in childhood-onset epilepsy. Epil. Behav., 2004, 5: 937–944.10.1016/j.yebeh.2004.08.00815582842
  61. Sillanpää M.:Social functioning and seizure status of young adults with onset of epilepsy in childhood. An epidemiological 20-year follow-up study. Acta Neurol. Scand., Suppl. 1983, 68 Suppl., 96: 1–81.10.1111/j.1600-0404.1983.tb01529.x
  62. Sillanpää M.:The influence of childhood epilepsy on potential adult employability. Int. J. Rehab. Res., 1977, 1: 27–33.
  63. Sillanpää M.:Medico-social prognosis of children with epilepsy. Epidemiological study and analysis of 245 patients. Acta Paedi-atr. Scand., 1973, 237 (Suppl. 68): 101–104.
  64. Sillanpää M.:Epidemiology and long-term Turku outcome of childhood-onset epilepsy and mortality. Personal experiences. Part I. J. Epileptol., 2015, 23: 136–144.10.1515/joepi-2015-0036
  65. Sillanpää M., Schmidt D.:Is incident drug-resistance of childhood-onset epilepsy reversible? A long-term follow-up study. Brain, 2012, 135: 2256–2262.10.1093/brain/aws06222499043
  66. Sillanpää M., Schmidt D.:Predicting antiepileptic drug response in children with epilepsy. Expert Rev. Neurother., 2011, 1: 877–885.10.1586/ern.11.1121651334
  67. Sillanpää M., Schmidt D.:Long-term employment of adults with childhood-onset epilepsy: a prospective population-based study. Epilepsia, 2010, 51: 1053–1060.10.1111/j.1528-1167.2009.02505.x20163443
  68. Sillanpää M., Schmidt D.:Early seizure frequency and aetiology predict long-term medical outcome in childhood-onset epilepsy. Brain, 2009a; 132: 989–998.10.1093/brain/awn35719153149
  69. Sillanpää M., Schmidt D.:Delayed time to first remission identifies poor long-term drug response of childhood-onset epilepsy: a prospective population-based study. Epil. Behav., 2009b, 16: 507–511.10.1016/j.yebeh.2009.08.02919793683
  70. Sillanpää M., Cross J.H.:The psychosocial impact of epilepsy in childhood. Epil. Behav., 2009, 15: Suppl., 5–10.10.1016/j.yebeh.2009.03.00719298867
  71. Sillanpää M., Schmidt D.:Seizure clustering during drug treatment affects seizure outcome and mortality of childhood-onset epilepsy. Brain, 2008, 131: 938–944.10.1093/brain/awn03718310680
  72. Sillanpää M., Schmidt D.:Natural history of treated childhoodonset epilepsy: prospective, long-term population-based study. Brain, 2006a, 129: 617–624.10.1093/brain/awh72616401617
  73. Sillanpää M., Schmidt D.:Prognosis of seizure recurrence after stopping antiepileptic drugs in seizure-free patients. A longterm population-based study of childhood-onset epilepsy. Epil. Behav., 2006b, 8: 713–719.10.1016/j.yebeh.2006.02.01416616648
  74. Sillanpää M., Shinnar S.:Obtaining a driver’s license and seizure relapse in patients with childhood-onset epilepsy. Neurology, 2005, 64: 680–686.10.1212/01.WNL.0000151957.80848.0E15728292
  75. Sillanpää M., Saarinen M., Schmidt D.:Clinical conditions of long-term cure in childhood-onset epilepsy: a 45-year follow-up study. Epilepsy Behav., 2014, 37: 49–53.10.1016/j.yebeh.2014.05.02924975821
  76. Sillanpää M., Saarinen M., Schmidt D.:Long-term risks following first remission in childhood-onset epilepsy. A populationbased study. Epil. Behav., 2012, 25: 145–152.10.1016/j.yebeh.2012.07.01523032120
  77. Sillanpää M., Haataja L., Shinnar S.:Perceived impact of childhood-onset epilepsy on quality of life as an adult. Epilepsia, 2004, 45: 971–977.10.1111/j.0013-9580.2004.44203.x15270765
  78. Sillanpää M., Camfield P., Camfield C.:Predicting long-term outcome of childhood epilepsy in Nova Scotia, Canada, and Turku, Finland. Validation of a simple scoring system. Arch. Neurol., 1995, 52: 589–592.10.1001/archneur.1995.005403000630147763207
  79. Sillanpää M., Jalava M., Kaleva O., Shinnar S.:Long-term prognosis of seizures with onset in childhood. N. Engl. J. Med., 1998, 338: 1715–1722.10.1056/NEJM1998061133824029624191
  80. Sillanpää M., Besag F., Aldenkamp A., Caplan R., Dunn D., Gobbi G.:Epidemiology of psychiatric/behavioural disorder in children with epilepsy. Epil. Disord. In press.
  81. Sillanpää M., Anttinen A., Rinne J.O., Joutsa J., Sonninen P., Erkinjuntti M. et al.:Childhood-onset epilepsy five decades later. A prospective population-based cohort study. Epilepsia, 2015, 56: 1774–1783.10.1111/epi.1318726434398
  82. Sillanpää M., Shinnar S.:Status epilepticus in a populationbased cohort with childhood-onset epilepsy in Finland. Ann. Neurol., 2002, 52: 303–310.10.1002/ana.1028612205642
  83. Sillanpää M., Urponen H.:Pitkäaikaissairaat ja vammaiset lapset Turun ja Porin läänissä. Yleisyys, sosiaalinen tausta ja kuntoutuspalvelut [Children with long-term illnesses, disabilities and handicaps. Prevalence, social background and handicaps]. National Medical Board of Finland, Helsinki 1984.
  84. Snead I., O.C., Donner E.J.:A new generation of anticonvulsants for the treatment of epilepsy in children. Paediatr. Child. Health, 2007, 12: 741–744.10.1093/pch/12.9.741253286619030458
  85. Suurmeijer T.P., Reuvekamp M.F., Aldenkamp B.P.:Social functioning, psychological functioning, and quality of life in epilepsy. Epilepsia, 2001, 42: 1160–1168.10.1046/j.1528-1157.2001.37000.x
  86. Todt H.:The late prognosis of epilepsy in childhood: results of a prospective follow-up study. Epilepsia, 1984, 25: 137–144.10.1111/j.1528-1157.1984.tb04169.x
  87. Wallace H., Shorvon S., Tallis R.:Age-specific incidence and prevalence rates of treated epilepsy in an unselected population of2 052 922 and age-specific fertility rates of women with epilepsy. Lancet, 1998, 352: 1970–1973.10.1016/S0140-6736(98)04512-7
  88. World Health Organization:International classification of impairments, disabilities and handicaps. A manual of classification relating to the consequences of disease. WHO, Geneva 1980.
DOI: https://doi.org/10.21307/joepi-2016-0001 | Journal eISSN: 2299-9728 | Journal ISSN: 2300-0147
Language: English
Page range: 25 - 39
Submitted on: Jan 7, 2016
|
Accepted on: Jan 18, 2016
|
Published on: Jan 25, 2016
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year

© 2016 Matti Sillanpää, published by The Foundation of Epileptology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.